Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement

working group members

Research output: Contribution to journalArticle

Abstract

The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus–positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.

Original languageEnglish (US)
Pages (from-to)418-432
Number of pages15
JournalJournal of Heart and Lung Transplantation
Volume39
Issue number5
DOIs
StatePublished - May 2020

Keywords

  • HCV
  • HCV+ cardiothoracic transplant
  • HCV+ transplant
  • consensus
  • donor
  • hepatitis C virus

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint Dive into the research topics of 'Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement'. Together they form a unique fingerprint.

  • Cite this